Omid Reza Zekavat
Overview
Explore the profile of Omid Reza Zekavat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
89
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zohalinezhad M, Barkhori S, Zekavat O, Namjoyan F, Bordbar M, Hashempur M
Support Care Cancer
. 2025 Jan;
33(2):117.
PMID: 39847133
Leukemia is a prevalent cancer that severely affects children, and standard chemotherapy often leads to severe gastrointestinal symptoms and neutropenia. This study aimed to discover alternative treatments to prevent neutropenia...
2.
Bordbar S, Shahriari M, Zekavat O, Mottaghipisheh H, Haghpanah S, Bordbar M
BMC Cancer
. 2024 Nov;
24(1):1388.
PMID: 39533245
Background: Wilms tumor (WT) is the most common malignant renal tumor in children. This study investigated the clinical features, pathological findings, and outcomes of children with malignant renal tumors in...
3.
Zekavat O, Movahednezhad Y, Shahsavani A, Haghpanah S, Shokrgozar N, Golmoghaddam H, et al.
Blood Res
. 2024 Apr;
59(1):17.
PMID: 38668798
No abstract available.
4.
Zekavat O, Movahednezhad Y, Shahsavani A, Haghpanah S, Shokrgozar N, Golmoghaddam H, et al.
Blood Res
. 2024 Apr;
59(1):16.
PMID: 38625415
Background: Development of antibodies against infused Factor VIII (FVIII) or "inhibitors" represents a major challenge following FVIII replacement therapy in patients with hemophilia A (HA). Recent studies have shown that...
5.
Zekavat O, Fallah Tafti F, Bordbar M, Parand S, Haghpanah S
J Pediatr Hematol Oncol
. 2023 Dec;
46(2):e137-e142.
PMID: 38132565
Objective: To determine the prevalence of iron overload in children with acute lymphoblastic leukemia (ALL) after treatment cessation and establish a cutoff value for serum ferritin level as an indicator...
6.
Bordbar M, Vahidifar M, Zarshenas M, Haghpanah S, Zareifar S, Shahriari M, et al.
Am J Blood Res
. 2023 Nov;
13(5):143-151.
PMID: 38023416
Introduction: Febrile neutropenia is a serious complication of cancer chemotherapy that can result in delays in treatment. This study evaluates the efficacy of L. at neutrophil recovery time in children...
7.
Bordbar M, Beigipour R, Tahami M, Zekavat O, Haghpanah S, Moshfeghinia R
J Orthop Surg Res
. 2023 Nov;
18(1):907.
PMID: 38017431
Background: Arthropathy is a common complication in patients with hemophilia. We examined the prevalence of this skeletal complication in patients with hemophilia who were registered at a Comprehensive Hemophilia Center...
8.
Safaei N, Kamran H, Anbardar M, Bordbar M, Zekavat O, Forooghi M
Case Rep Oncol
. 2023 Oct;
16(1):1041-1047.
PMID: 37900809
Teratoma is a type of germ cell tumor layer that appears in the gonadal, sacrococcygeal, mediastinal, and retroperitoneal regions. Primary retroperitoneal teratoma is rare and asymptomatic but can present with...
9.
Arandi N, Zekavat O, Shokrgozar N, Shahsavani A, Golmoghaddam H, Kalani M
Int J Lab Hematol
. 2023 Jul;
45(6):953-960.
PMID: 37488961
Introduction: The development of anti-factor VIII (FVIII) antibodies or "inhibitors" is a major complication following FVIII replacement therapy in patients with severe hemophilia A (HA), rendering the treatment inefficient. Data...
10.
Rahimi K, Amoozgar H, Zareifar S, Shahriari M, Zekavat O, Karimi M, et al.
Egypt Heart J
. 2023 Mar;
75(1):21.
PMID: 36961611
Background: Cardiotoxicity is a major concern following doxorubicin (DOX) use in the treatment of malignancies. We aimed to investigate whether deferoxamine (DFO) can prevent acute cardiotoxicity in children with cancer...